June 2, 2026 · Form 4 insider transaction
Countouriotis Athena bought 7,490 shares of BioMarin Pharmaceutical Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Restricted stock units granted on June 2, 2026. Price not applicable.